All public logs
Jump to navigation
Jump to search
Combined display of all available logs of wikidoc. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 22:39, 25 April 2024 Alara E. Dagsali talk contribs created page User:AED (Created page with "==Alara Ece Dagsali== '''Alara Ece Dagsali''' <br>'''Contact:''' email: alaraecedagsai99@gmail.com; +905313614710 ==Medical Education== *School of Medicine (M.D.): Istanbul Medipol University 2021- 2024 Demiroglu Bilim University 2018-2021 ==Pages authored/Co-authored/Collaborated== ===2023=== ====Authored:==== *Reni Syndrome ==Work Experience== *Wikidoc - Associate Editor-In-Chief, 2023 - Current *Yeditepe University Hospitals Cardiac Electrophysiology Lab, Ista...")
- 15:23, 25 April 2024 Alen Antony talk contribs created page Daprodustat (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=daprodustat |aOrAn=a |drugClass=reversible inhibitor of HIF-PH1, PH2 and PH3. |indicationType=treatment |indication=anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least four months. |hasBlackBoxWarning=Yes |adverseReactions=Hypertension, Abdominal pain, Dizzines, Hypersensitivity, and thrombotic vascular events like Myocardial infarction, stroke, pulmonary embolism,...")
- 23:04, 24 April 2024 Kosar Doraghi talk contribs created page File:IMG 1177.jpeg
- 23:04, 24 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 1177.jpeg
- 22:59, 24 April 2024 Kosar Doraghi talk contribs created page File:IMG 1176.jpeg
- 22:59, 24 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 1176.jpeg
- 21:21, 24 April 2024 Alara E. Dagsali talk contribs created page Template:AlaraE.Dagsali (Created page with " Alara Ece Dagsali, M.D.[mailto:alaraecedagsali99@gmail.com]")
- 21:14, 24 April 2024 Alara E. Dagsali talk contribs created page Tranexamic (Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E.Dagsali |genericName=Tranexamic |aOrAn=a |drugClass=hemophilia drug |indicationType=prevention |indication=Tranexamic acid injection is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. |adverseReactions=Thromboembolic Risk Seizures Hypersensitivity Reactions Visual Disturbances Dizzines...")
- 21:06, 24 April 2024 Alen Antony talk contribs created page Bexagliflozin (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=bexagliflozin }}")
- 15:32, 23 April 2024 User account Malaika Hassan talk contribs was created by Alberto Castro Molina talk contribs
- 18:44, 22 April 2024 Alara E. Dagsali talk contribs created page File:D2f97c72-bbfb-426e-b742-6e25234ba1ff 2.jpg
- 18:44, 22 April 2024 Alara E. Dagsali talk contribs uploaded File:D2f97c72-bbfb-426e-b742-6e25234ba1ff 2.jpg
- 18:43, 22 April 2024 Alara E. Dagsali talk contribs created page File:Ae8d4ea7-c895-403b-a435-56dc4996a3b0.JPG
- 18:43, 22 April 2024 Alara E. Dagsali talk contribs uploaded File:Ae8d4ea7-c895-403b-a435-56dc4996a3b0.JPG
- 03:48, 21 April 2024 Kosar Doraghi talk contribs created page File:IMG 1052.jpeg
- 03:48, 21 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 1052.jpeg
- 03:47, 21 April 2024 Kosar Doraghi talk contribs created page BRENZAVVY- bexagliflozin (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=BRENZAVVY- bexagliflozin |aOrAn=a |drugClass=sodium-glucose co-transporter 2 (SGLT2) inhibitor |indicationType=treatment |indication=glycemic control in adults with type 2 diabetes mellitus |hasBlackBoxWarning=Yes |adverseReactions=female genital mycotic infections, urinary tract infection and increased urination |blackBoxWarningTitle=Warnings |blackBoxWarningBody=*Not re...")
- 03:43, 21 April 2024 Kosar Doraghi talk contribs created page File:IMG 1050.jpeg
- 03:43, 21 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 1050.jpeg
- 03:40, 21 April 2024 Kosar Doraghi talk contribs created page File:IMG 1051.jpeg
- 03:40, 21 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 1051.jpeg
- 03:34, 21 April 2024 Kosar Doraghi talk contribs created page File:IMG 1049.jpeg
- 03:34, 21 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 1049.jpeg
- 16:05, 20 April 2024 Imam Ali Shah talk contribs created page Template:IAS (Created page with "Associate Editor-In-Chief: Imam Ali Shah, MBBS; Chandka Medical College, Larkana Pakistan")
- 16:30, 19 April 2024 Kosar Doraghi talk contribs created page Sparsentan (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi[mailto:k.doraghi@yahoo.com] |genericName=sparsentan |aOrAn=an |drugClass=endothelin and angiotensin II receptor antagonist |indicationType=treatment |indication=proteinuria(reduce) in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression, generally a urine protein-to-creatinine ratio (UPCR) ≥1.5 g/g |hasBlackBoxWarning=Yes |adverseReactions=Hepatotoxicity, Embryo-Fetal Tox...")
- 16:24, 19 April 2024 Kosar Doraghi talk contribs created page File:IMG 1046.jpeg
- 16:24, 19 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 1046.jpeg
- 16:14, 19 April 2024 Kosar Doraghi talk contribs created page File:IMG 1045.jpeg
- 16:14, 19 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 1045.jpeg
- 16:11, 19 April 2024 Kosar Doraghi talk contribs created page File:IMG 1047.jpeg
- 16:11, 19 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 1047.jpeg
- 16:05, 19 April 2024 Kosar Doraghi talk contribs created page File:IMG 1044.jpeg
- 16:05, 19 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 1044.jpeg
- 19:33, 17 April 2024 Hafiza Amna Qadeer talk contribs created page SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY (Created blank page)
- 08:08, 17 April 2024 Edzelco talk contribs created page Elranatamab-bcmm (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:08, 17 April 2024 Edzelco talk contribs created page Palovarotene (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:08, 17 April 2024 Edzelco talk contribs created page Pozelimab-bbfg (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:07, 17 April 2024 Edzelco talk contribs created page Motixafortide (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:07, 17 April 2024 Edzelco talk contribs created page Momelotinib (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:06, 17 April 2024 Edzelco talk contribs created page Cipaglucosidase alfa-atga (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:05, 17 April 2024 Edzelco talk contribs created page Etrasimod (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:05, 17 April 2024 Edzelco talk contribs created page Zilucoplan (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:04, 17 April 2024 Edzelco talk contribs created page Bimekizumab (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:04, 17 April 2024 Edzelco talk contribs created page Vamorolone (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:04, 17 April 2024 Edzelco talk contribs created page Mirikizumab-mrkz (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:03, 17 April 2024 Edzelco talk contribs created page Toripalimab-tpzi (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:02, 17 April 2024 Edzelco talk contribs created page Fruquintinib (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=fruquintinib |aOrAn=a |drugClass=kinase inhibitor |indicationType=treatment |indication=adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine‑, oxaliplatin‑, and irinotecan‑based chemotherapy, an anti‑VEGF therapy, and, if RAS wild‑type and medically appropriate, an anti-EGFR therapy |fdaLIADAdult=Recommended Dosage The recommended dose of F...")
- 07:52, 17 April 2024 Edzelco talk contribs created page Taurolidine, heparin (Created page with "{{DrugProjectFormSinglePage |authorTag={{Edzelco}} |genericName=taurolidine, heparin |aOrAn=a |drugClass=combination of taurolidine, a thiadiazinane antimicrobial, and heparin, an anti-coagulant |indicationType=prevention |indication=atheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis (HD) through a central venous catheter (CVC). This drug is indicated for use in a limited and specific population of patients...")
- 07:43, 17 April 2024 Edzelco talk contribs created page Repotrectinib (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=repotrectinib |aOrAn=a |drugClass=kinase inhibitor |indicationType=treatment |indication=adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) |contraindications=None |warnings=5.1 Central Nervous System Adverse Reactions AUGTYRO can cause central nervous system adverse reactions. Among the 351 patients who received AUGTYRO in Study TRIDENT-1, a broad spectru...")
- 07:32, 17 April 2024 Edzelco talk contribs created page Efbemalenograstim alfa-vuxw (Created page with "{{DrugProjectFormSinglePage |genericName=efbemalenograstim alfa-vuxw |aOrAn=a |drugClass=leukocyte growth factor |indicationType=prevention |indication=incidence of infection, as manifested by febrile neutropenia, in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia |fdaLIADAdult=Recommended Dose: 20 mg administered subcutaneously once per chemotherapy cycle....")